The Skill to Heal. The Heart to Care.

Phone: 505.842.8171

dotAfter Hours: 505.857.3877

dotPharmacy: 505.822.3911




Latest Cancer News

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (12-19-2014)

Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Suppression of Ovarian Function Trial (SOFT) presented at... Continue Reading

Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer (12-19-2014)

More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer,  developed at Massachusetts... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (12-18-2014)

Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical Oncology. Cancer... Continue Reading

PD-1 Immunotherapy Shows Promise in Hodgkin’s Lymphoma (12-18-2014)

The cancer immunotherapy strategy known as programmed cell death 1 (PD-1) has generated great excitement for its ability to help the immune system recognize and attack cancer. Now according to researcher recently published in The New England Journal of... Continue Reading

Some Older Women with Early-Stage Breast Cancer May Be Receiving Radiation That Is Unlikely to Add Benefit (12-17-2014)

Up to two-thirds of older women with early-stage breast cancer may be receiving radiation therapy that may not provide additional benefit. These findings were recently released online by the journal Cancer.[1] The goal of radiation therapy in early breast... Continue Reading

HIV-Positive Patients with Lymphoma Should No Longer be Excluded From Receiving Blood Stem Cell Transplants as Treatment (12-17-2014)

HIV-positive patients with lymphoma were previously excluded from receiving autologous blood stem cell transplants as treatment, because of concern that these patients’ compromised immune systems would have a higher risk of infection and poor graft... Continue Reading

Jakafi® Helps Maintain Blood Cells Levels in Polycythemia Vera (12-16-2014)

CancerConnect News: A new drug called Jakafi® (ruxolitinib) appears to help patients with polycythemia vera (PV) maintain hematocrit control more effectively than best available therapy. These findings were presented at the 56th American Hematology Society... Continue Reading

IBIS-I Trial Confirms Greater Than Fifteen Year Benefit of Tamoxifen to Reduce Risk of Breast Cancer in High-Risk Women (12-16-2014)

Long term results of the International Breast Cancer Intervention Study-I (IBIS-I) were presented at the 2014 San Antonio Breast Cancer Symposium, confirming that tamoxifen significantly decreased the risk of developing breast cancer in high-risk women. The... Continue Reading

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (12-15-2014)

Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication that targets HER2 as well as HER4 and the epidermal growth factor... Continue Reading

Switching from Best Available Therapy to Jakafi® Improves Outcomes in Polycythemia Vera (12-15-2014)

Patients with polycythemia vera (PV) who begin treatment with best available therapy and then switch to treatment with Jakafi® (ruxolitinib) experience improved outcomes. These findings were presented at the 56th American Hematological Society Annual... Continue Reading

Daratumumab Anti-CD38 Monoclonal Antibody Appears Promising For the Treatment of Multiple Myeloma (12-15-2014)

An investigational new class of drugs, the anti-CD38 monoclonal antibodies, could be the next major advance in the treatment of multiple myeloma. These findings were presented at the 56th American Hematological Society Annual Meeting and Exposition, December... Continue Reading

Breastfeeding Reduces Risk of Developing Breast Cancer (12-12-2014)

Breastfeeding could cut the chance of developing breast cancer by up to one fifth according to researchers sharing the results of a major clinical study presented at the 2014 San Antonio Breast Cancer Symposium.1 Previous studies have suggested that breastfeeding... Continue Reading

Next Page »